| 12001 | Current employment status - In paid employment or self-employed | Employment | UKBB00000158 | 3.31e-06 |
| 12002 | CDC37/PPP1R12A ratio | GCST90313934 | 3.31e-06 |
| 12003 | CDKN1A/TACC3 ratio | GCST90313975 | 3.28e-06 |
| 12004 | OSM levels | GCST90470133 | 3.26e-06 |
| 12005 | Cholesteryl esters to total lipids in large HDL percentage (UKB data field 23636) | GCST90269733 | 3.25e-06 |
| 12006 | PPME1/PSMD9 ratio | GCST90315705 | 3.25e-06 |
| 12007 | IFNG levels | GCST90469515 | 3.24e-06 |
| 12008 | FOLR2 levels | GCST90469260 | 3.23e-06 |
| 12009 | CSF1/IFNGR1 ratio | GCST90314283 | 3.22e-06 |
| 12010 | Other disorders of fluid, electrolyte and acid-base balance | FING00001027 | 3.18e-06 |
| 12011 | Mean corpuscular hemoglobin | GCST004630 | 3.18e-06 |
| 12012 | DBNL/DNAJA2 ratio | GCST90314415 | 3.15e-06 |
| 12013 | CD1C/CD207 ratio | GCST90313745 | 3.14e-06 |
| 12014 | HTRA2/SIAE ratio | GCST90315097 | 3.14e-06 |
| 12015 | Other and unspecified nerve root and plexus disorders, also in other diseases | FING00000944 | 3.12e-06 |
| 12016 | Concentration of LDL particles | GCST90498413 | 3.11e-06 |
| 12017 | Suffer from 'nerves' | Mental health | UKBB00000799 | 3.10e-06 |
| 12018 | BST2 levels | GCST90468475 | 3.09e-06 |
| 12019 | Mean corpuscular hemoglobin | GCST90002390 | 3.09e-06 |
| 12020 | Saturated fatty acid levels | GCST90092980 | 3.07e-06 |
| 12021 | CD58/IFNGR1 ratio | GCST90313849 | 3.04e-06 |
| 12022 | Omega-3 fatty acids to total fatty acids percentage | GCST90502460 | 3.04e-06 |
| 12023 | APP/HBEGF ratio | GCST90313324 | 3.03e-06 |
| 12024 | SIGLEC1 levels | GCST90470632 | 3.02e-06 |
| 12025 | F9/FURIN ratio | GCST90314747 | 3.01e-06 |
| 12026 | ULBP2 levels | GCST90471008 | 3.00e-06 |
| 12027 | Total triglycerides levels | GCST90092992 | 2.99e-06 |
| 12028 | Mouth/teeth dental problems - Mouth ulcers | Mouth | UKBB00000488 | 2.97e-06 |
| 12029 | Symbol digit substitution test performance (baseline) | GCST90565841 | 2.96e-06 |
| 12030 | CR1 levels | GCST90468851 | 2.96e-06 |
| 12031 | Erythematosquamous dermatosis (PheCode 690) | GCST90476170 | 2.94e-06 |
| 12032 | KLRD1/LY9 ratio | GCST90315261 | 2.94e-06 |
| 12033 | Total fatty acid levels | GCST90092987 | 2.90e-06 |
| 12034 | Recent feelings of foreboding | Anxiety | UKBB00000738 | 2.86e-06 |
| 12035 | Loneliness, isolation | Mental health | UKBB00000408 | 2.86e-06 |
| 12036 | FCRL6/KLRD1 ratio | GCST90314807 | 2.82e-06 |
| 12037 | Mean corpuscular haemoglobin (UKB data field 30050) | GCST90468084 | 2.79e-06 |
| 12038 | RARRES2/ST6GAL1 ratio | GCST90315759 | 2.76e-06 |
| 12039 | Red cell distribution width | GCST90025988 | 2.75e-06 |
| 12040 | Triglycerides in very small VLDL | GCST90500885 | 2.73e-06 |
| 12041 | Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587) | GCST90269684 | 2.72e-06 |
| 12042 | eosinophil (absolute count, maximum, inv-norm transformed) | GCST90475288 | 2.72e-06 |
| 12043 | IL12RB1 levels | GCST90469550 | 2.71e-06 |
| 12044 | Oxalate (ethanedioate) levels | GCST90199672 | 2.69e-06 |
| 12045 | neutrophil (fraction, mean, inv-norm transformed) | GCST90475538 | 2.66e-06 |
| 12046 | Reason for reducing amount of alcohol drunk - Other reason | Alcohol | UKBB00000735 | 2.65e-06 |
| 12047 | Types of transport used (excluding work) - Cycle | Physical activity | UKBB00000877 | 2.64e-06 |
| 12048 | KLRD1 levels | GCST90469711 | 2.64e-06 |
| 12049 | Concentration of large LDL particles | GCST90498037 | 2.62e-06 |
| 12050 | ADH4/SCLY ratio | GCST90313195 | 2.61e-06 |
| 12051 | Total fatty acid levels | GCST90502710 | 2.61e-06 |
| 12052 | Obesity | FING00000895 | 2.58e-06 |
| 12053 | Saturated fatty acids to total fatty acids percentage | GCST90499958 | 2.55e-06 |
| 12054 | Takes medication for Skin condition (ex. Eczema, Psoriasis)? | GCST90475275 | 2.53e-06 |
| 12055 | Alcohol drinker status - Current | Alcohol | UKBB00000021 | 2.51e-06 |
| 12056 | Phospholipids to total lipids ratio in medium VLDL | GCST90092925 | 2.50e-06 |
| 12057 | FABP3 levels | GCST90469175 | 2.48e-06 |
| 12058 | Triglyceride levels in small LDL | GCST90092966 | 2.47e-06 |
| 12059 | C1RL levels | GCST90468492 | 2.43e-06 |
| 12060 | SDC4 levels | GCST90470559 | 2.42e-06 |
| 12061 | Alzheimer's disease (MTAG) | GCST90449058 | 2.40e-06 |
| 12062 | Alzheimer's disease or family history of Alzheimer's disease | GCST90012877 | 2.36e-06 |
| 12063 | CLPP levels | GCST90468785 | 2.34e-06 |
| 12064 | Hypothyroidism | GCST90319320 | 2.30e-06 |
| 12065 | Hypothyroidism | GCST90468138 | 2.30e-06 |
| 12066 | Treatment or medication use - insulin product (UKB data field 20003_1140883066) | GCST90042226 | 2.29e-06 |
| 12067 | F-fatty/dairy food liking (derived food-liking factor) | GCST90094760 | 2.28e-06 |
| 12068 | Pure hypercholesterolaemia | FING00001230 | 2.27e-06 |
| 12069 | Total lipid levels in small HDL | GCST90092950 | 2.22e-06 |
| 12070 | Omega-3 fatty acid levels | GCST90502055 | 2.18e-06 |
| 12071 | CDKN1A/TXLNA ratio | GCST90313979 | 2.15e-06 |
| 12072 | F-fruit liking (derived food-liking factor) | GCST90094767 | 2.15e-06 |
| 12073 | Basophil percentage of white cells | GCST90002380 | 2.11e-06 |
| 12074 | Cholelithiasis | Disorders of gallbladder, biliary tract and pancreas | UKBB00000132 | 2.09e-06 |
| 12075 | Cholesteryl esters to total lipids ratio in small LDL | GCST90092959 | 2.07e-06 |
| 12076 | Alzheimer's disease or family history of Alzheimer's disease | GCST007320 | 2.07e-06 |
| 12077 | Degree of unsaturation | GCST90502746 | 2.06e-06 |
| 12078 | Clonal haematopoiesis of indeterminate potential (with or without mosaic chromosomal alteration) | GCST90165267 | 2.04e-06 |
| 12079 | mean corpuscular volume (MCV, maximum, inv-norm transformed) | GCST90475466 | 2.03e-06 |
| 12080 | PLXNB2/SEMA7A ratio | GCST90315692 | 2.02e-06 |
| 12081 | 3-methyl-2-oxobutyrate levels | GCST90199677 | 2.02e-06 |
| 12082 | AIF1 levels | GCST90468267 | 1.95e-06 |
| 12083 | Pregnenolone sulfate levels | GCST90199873 | 1.92e-06 |
| 12084 | Chronic sinusitis (PheCode 475) | GCST90476020 | 1.89e-06 |
| 12085 | Crohn's disease | GCST90475318 | 1.88e-06 |
| 12086 | Triglyceride levels in IDL | GCST90092841 | 1.88e-06 |
| 12087 | CLC levels | GCST90468762 | 1.85e-06 |
| 12088 | Cholelithiasis | digestive | UKBB00000131 | 1.83e-06 |
| 12089 | AK1/PEBP1 ratio | GCST90313225 | 1.82e-06 |
| 12090 | FCRL1/TCL1A ratio | GCST90314795 | 1.80e-06 |
| 12091 | Addison's disease | GCST90011871 | 1.75e-06 |
| 12092 | A1BG levels | GCST90468185 | 1.75e-06 |
| 12093 | LRTM2 levels | GCST90469808 | 1.74e-06 |
| 12094 | Pain in joint (PheCode 745) | GCST90476262 | 1.73e-06 |
| 12095 | Alzheimer's disease (late onset) | GCST002245 | 1.72e-06 |
| 12096 | F2R/SPINT2 ratio | GCST90314737 | 1.70e-06 |
| 12097 | Triglyceride levels in small VLDL | GCST90092978 | 1.70e-06 |
| 12098 | PCDH17 levels | GCST90470169 | 1.68e-06 |
| 12099 | Basophil count | GCST90025997 | 1.67e-06 |
| 12100 | Red cell distribution width | GCST006804 | 1.67e-06 |
| 12101 | Triglycerides x anxiety interaction (2df test) | GCST90570677 | 1.67e-06 |
| 12102 | Mean corpuscular volume | Blood count | UKBB00000449 | 1.66e-06 |
| 12103 | Cigarettes smoked per day (MTAG) | GCST90179151 | 1.64e-06 |
| 12104 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90499340 | 1.64e-06 |
| 12105 | CLEC1A/CLEC7A ratio | GCST90314083 | 1.62e-06 |
| 12106 | RARRES2 levels | GCST90470428 | 1.61e-06 |
| 12107 | Overweight, obesity and other hyperalimentation | endocrine/metabolic | UKBB00000622 | 1.59e-06 |
| 12108 | Ectropion or entropion (PheCode 374.1) | GCST90475891 | 1.54e-06 |
| 12109 | Average diameter for LDL particles | GCST90498458 | 1.52e-06 |
| 12110 | CD22/FOLR2 ratio | GCST90313758 | 1.49e-06 |
| 12111 | Cholesteryl Esters in Medium LDL | GCST90498739 | 1.48e-06 |
| 12112 | KLRB1/KLRD1 ratio | GCST90315260 | 1.48e-06 |
| 12113 | CRLF1 levels | GCST90468868 | 1.48e-06 |
| 12114 | MBL2 levels | GCST90469868 | 1.45e-06 |
| 12115 | Phospholipids to total lipids ratio in small LDL | GCST90092965 | 1.43e-06 |
| 12116 | Saturated fatty acids to total fatty acids percentage (UKB data field 23455) | GCST90269552 | 1.42e-06 |
| 12117 | red cell diameter width (RDW, mean, inv-norm transformed) | GCST90476361 | 1.41e-06 |
| 12118 | Pyruvate levels | GCST90092942 | 1.38e-06 |
| 12119 | ADH4/DCXR ratio | GCST90313190 | 1.38e-06 |
| 12120 | Red cell distribution width | GCST004621 | 1.37e-06 |
| 12121 | Sarcoidosis | GCST90503483 | 1.37e-06 |
| 12122 | Spondylopathies (FG) | FING00001326 | 1.35e-06 |
| 12123 | Obesity | endocrine/metabolic | UKBB00000544 | 1.35e-06 |
| 12124 | Omega-6 fatty acids to total fatty acids percentage | GCST90502121 | 1.35e-06 |
| 12125 | CD74/TIMD4 ratio | GCST90313896 | 1.31e-06 |
| 12126 | Red cell distribution width | GCST90002404 | 1.29e-06 |
| 12127 | Obesity | Obesity and other hyperalimentation | UKBB00000545 | 1.27e-06 |
| 12128 | Triglycerides in very large VLDL | GCST90500671 | 1.23e-06 |
| 12129 | Ratio of omega-6 fatty acids to total fatty acids | GCST90092935 | 1.20e-06 |
| 12130 | Melanoma | GCST90011809 | 1.19e-06 |
| 12131 | HNRNPK/USP8 ratio | GCST90315070 | 1.18e-06 |
| 12132 | CD300E levels | GCST90468621 | 1.15e-06 |
| 12133 | Cholesterol to total lipids ratio in small HDL | GCST90092945 | 1.14e-06 |
| 12134 | CHIT1 levels | GCST90468744 | 1.09e-06 |
| 12135 | ALB/Globulin ratio | UKBB00000020 | 1.01e-06 |
| 12136 | Phospholipids to Total Lipids in Small HDL percentage | GCST90499494 | 9.84e-07 |
| 12137 | ACY3 levels | GCST90468213 | 9.82e-07 |
| 12138 | KLKB1 levels | GCST90469708 | 9.72e-07 |
| 12139 | SCGB3A2 levels | GCST90470543 | 9.54e-07 |
| 12140 | IL1R1/IL1RN ratio | GCST90315158 | 9.36e-07 |
| 12141 | Chronic obstructive pulmonary disease in current smokers | GCST90016593 | 9.23e-07 |
| 12142 | Total lipid levels in medium VLDL | GCST90092922 | 9.06e-07 |
| 12143 | neutrophil (fraction, maximum, inv-norm transformed) | GCST90475535 | 8.65e-07 |
| 12144 | Biological Sibling: Cancer, Skin | GCST90476369 | 8.60e-07 |
| 12145 | ADGRE2 levels | GCST90468237 | 8.44e-07 |
| 12146 | LDLR levels | GCST90469750 | 8.25e-07 |
| 12147 | BCAM/SEMA7A ratio | GCST90313476 | 8.20e-07 |
| 12148 | Phospholipids in medium LDL | GCST90498832 | 8.08e-07 |
| 12149 | GP1BA/SDC4 ratio | GCST90314957 | 7.90e-07 |
| 12150 | KIFBP/LYN ratio | GCST90315246 | 7.88e-07 |
| 12151 | IL6 levels | GCST90469604 | 7.86e-07 |
| 12152 | F-cake/biscuits liking (derived food-liking factor) | GCST90094722 | 7.83e-07 |
| 12153 | Omega-3 fatty acids to total fatty acids percentage | GCST90502087 | 7.48e-07 |
| 12154 | 1-stearoylglycerophosphoethanolamine levels | GCST90243780 | 7.36e-07 |
| 12155 | MEP1A levels | GCST90469887 | 7.35e-07 |
| 12156 | Takes medication for Thyroid problems? | GCST90475277 | 7.31e-07 |
| 12157 | Mineral and other dietary supplements - Calcium | Medication | UKBB00000471 | 7.28e-07 |
| 12158 | Type 1 diabetes | GCST90432066 | 7.13e-07 |
| 12159 | lymphocyte (fraction, maximum, inv-norm transformed) | GCST90475432 | 7.11e-07 |
| 12160 | Saturated fatty acids levels | GCST90499953 | 7.03e-07 |
| 12161 | Free cholesterol to total lipids ratio in very small VLDL | GCST90093033 | 6.96e-07 |
| 12162 | SDC4/SEMA4D ratio | GCST90315818 | 6.90e-07 |
| 12163 | Free cholesterol to total lipids ratio in small LDL | GCST90092961 | 6.77e-07 |
| 12164 | Cholesteryl esters to total lipids ratio in small HDL | GCST90092947 | 6.76e-07 |
| 12165 | mean corpuscular hemoglobin (MCH, mean, inv-norm transformed) | GCST90475446 | 6.43e-07 |
| 12166 | Glutamine levels | GCST90497282 | 6.42e-07 |
| 12167 | Mean corpuscular volume | GCST004602 | 6.28e-07 |
| 12168 | F-fatty/salty food liking (derived food-liking factor) | GCST90094759 | 6.28e-07 |
| 12169 | KLK13 levels | GCST90469699 | 6.15e-07 |
| 12170 | TCL1A/TNFRSF13C ratio | GCST90315912 | 6.00e-07 |
| 12171 | BST2/CEACAM1 ratio | GCST90313537 | 5.70e-07 |
| 12172 | CSF3 levels | GCST90468886 | 5.60e-07 |
| 12173 | CD300C levels | GCST90468620 | 5.59e-07 |
| 12174 | Cholesterol to total lipids ratio in large VLDL | GCST90092869 | 5.57e-07 |
| 12175 | Cholesterol to total lipids ratio in medium VLDL | GCST90092917 | 5.50e-07 |
| 12176 | PDCD1/TNFRSF9 ratio | GCST90315611 | 5.42e-07 |
| 12177 | Mean corpuscular haemoglobin | Blood count | UKBB00000447 | 5.36e-07 |
| 12178 | Free cholesterol to total lipids ratio in small VLDL | GCST90092973 | 5.06e-07 |
| 12179 | Basophil percentage of white cells | GCST004631 | 5.04e-07 |
| 12180 | Thyroid problems | GCST90475276 | 4.94e-07 |
| 12181 | Triglyceride levels in medium HDL | GCST90092902 | 4.85e-07 |
| 12182 | HBEGF/SDC4 ratio | GCST90315037 | 4.76e-07 |
| 12183 | Acute upper respiratory infections | FING00000034 | 4.66e-07 |
| 12184 | NFATC3 levels | GCST90470034 | 4.59e-07 |
| 12185 | GBP1 levels | GCST90469311 | 4.56e-07 |
| 12186 | Monounsaturated fatty acid levels | GCST90092928 | 4.52e-07 |
| 12187 | Operation code - cholecystectomy/gall bladder removal | Operations | UKBB00000554 | 4.47e-07 |
| 12188 | CD164/CD99 ratio | GCST90313740 | 4.40e-07 |
| 12189 | PTPRR levels | GCST90470386 | 4.39e-07 |
| 12190 | Irritable bowel syndrome | GCST90016564 | 4.29e-07 |
| 12191 | F-cheese liking (derived food-liking factor) | GCST90094729 | 4.20e-07 |
| 12192 | BCAM/LGALS4 ratio | GCST90313473 | 4.05e-07 |
| 12193 | CD27/NECTIN4 ratio | GCST90313775 | 4.03e-07 |
| 12194 | Phospholipid levels in small HDL | GCST90092952 | 3.97e-07 |
| 12195 | CDH2 levels | GCST90468673 | 3.93e-07 |
| 12196 | Cholesteryl esters to total lipids ratio in small VLDL | GCST90092971 | 3.69e-07 |
| 12197 | LCN2 levels | GCST90469747 | 3.67e-07 |
| 12198 | CCN2/HBEGF ratio | GCST90313713 | 3.58e-07 |
| 12199 | Red cell distribution width | GCST90002369 | 3.57e-07 |
| 12200 | lymphocyte (fraction, mean, inv-norm transformed) | GCST90475435 | 3.56e-07 |
| 12201 | Basophill percentage | Blood count | UKBB00000087 | 3.53e-07 |
| 12202 | IL18BP/ROR1 ratio | GCST90315155 | 3.51e-07 |
| 12203 | IDP dMRI TBSS ISOVF Genu of corpus callosum | GCST90004479 | 3.47e-07 |
| 12204 | Schizophrenia or delusion (more control exclusions) | FING00001278 | 3.44e-07 |
| 12205 | CD63 levels | GCST90468642 | 3.39e-07 |
| 12206 | Positional arithmetic | Fluid intelligence / reasoning | UKBB00000654 | 3.37e-07 |
| 12207 | Triglyceride levels in HDL | GCST90092829 | 3.22e-07 |
| 12208 | CD163/FOLR2 ratio | GCST90313734 | 3.20e-07 |
| 12209 | IL22RA2 levels | GCST90090699 | 3.20e-07 |
| 12210 | Occupational attainment | GCST90102253 | 3.16e-07 |
| 12211 | Linoleic acid to total fatty acids percentage | GCST90502320 | 3.13e-07 |
| 12212 | Other diseases of upper respiratory tract | FING00001012 | 3.00e-07 |
| 12213 | Ulcerative ileocolitis | FING00001392 | 2.90e-07 |
| 12214 | CD163/DSC2 ratio | GCST90313733 | 2.87e-07 |
| 12215 | White blood cell count (basophil) | GCST004618 | 2.80e-07 |
| 12216 | Mean corpuscular volume | GCST90018746 | 2.67e-07 |
| 12217 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502074 | 2.64e-07 |
| 12218 | ICAM1/REG1A ratio | GCST90315114 | 2.64e-07 |
| 12219 | REST UKBBICA NODEamps25 0001 | GCST90385484 | 2.61e-07 |
| 12220 | Cholesteryl esters to total lipids ratio in large HDL | GCST90092847 | 2.55e-07 |
| 12221 | ADAM8 levels | GCST90468220 | 2.51e-07 |
| 12222 | FAM177A1 levels | GCST90242458 | 2.49e-07 |
| 12223 | Omega-3 fatty acids to total fatty acids percentage | GCST90502081 | 2.45e-07 |
| 12224 | mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed) | GCST90475442 | 2.42e-07 |
| 12225 | ADH4/SORD ratio | GCST90313196 | 2.42e-07 |
| 12226 | IL17RB levels | GCST90469563 | 2.41e-07 |
| 12227 | ARSA/CD164 ratio | GCST90313351 | 2.39e-07 |
| 12228 | ESAM/THPO ratio | GCST90314719 | 2.39e-07 |
| 12229 | FCAR levels | GCST90469197 | 2.36e-07 |
| 12230 | MILR1 levels | GCST90469907 | 2.34e-07 |
| 12231 | GYS1/TIA1 ratio | GCST90315004 | 2.31e-07 |
| 12232 | ADGRE5 levels | GCST90468238 | 2.12e-07 |
| 12233 | Disorders of skin appendages | FING00000460 | 2.10e-07 |
| 12234 | PLXNB2 levels | GCST90470266 | 2.06e-07 |
| 12235 | Triglycerides to Total Lipids in Large HDL percentage | GCST90497896 | 2.03e-07 |
| 12236 | Physical activity (Total log acceleration 10pm-12am) | GCST90061420 | 1.96e-07 |
| 12237 | FCGR2B levels | GCST90469201 | 1.96e-07 |
| 12238 | LYVE1 levels | GCST90469832 | 1.82e-07 |
| 12239 | Hard cheese liking | GCST90094778 | 1.81e-07 |
| 12240 | EFNA4 levels | GCST90469081 | 1.70e-07 |
| 12241 | DLL1/IL18BP ratio | GCST90314495 | 1.67e-07 |
| 12242 | Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers) | FING00001330 | 1.64e-07 |
| 12243 | CHI3L1/PRSS8 ratio | GCST90314044 | 1.57e-07 |
| 12244 | Immature fraction of reticulocytes | GCST004628 | 1.56e-07 |
| 12245 | Irritable bowel syndrome mixed subtype | GCST90243959 | 1.55e-07 |
| 12246 | Provencibacterium massiliense abundance in stool | GCST90032527 | 1.49e-07 |
| 12247 | FAM3B/FUT3_FUT5 ratio | GCST90314777 | 1.43e-07 |
| 12248 | ACP6 levels | GCST90468204 | 1.41e-07 |
| 12249 | red cell diameter width (RDW, maximum, inv-norm transformed) | GCST90476357 | 1.39e-07 |
| 12250 | Skin and soft tissue infections | GCST90013411 | 1.33e-07 |
| 12251 | CLEC4C levels | GCST90468772 | 1.31e-07 |
| 12252 | TSPAN1 levels | GCST90470978 | 1.27e-07 |
| 12253 | IL1RN/LGALS9 ratio | GCST90315160 | 1.26e-07 |
| 12254 | OSCAR/TNFRSF14 ratio | GCST90315588 | 1.23e-07 |
| 12255 | Triglycerides to total lipids ratio in medium VLDL | GCST90092927 | 1.21e-07 |
| 12256 | CST7 levels | GCST90468897 | 1.20e-07 |
| 12257 | CD163/IL18BP ratio | GCST90313736 | 1.07e-07 |
| 12258 | ADA2 levels | GCST90468215 | 1.05e-07 |
| 12259 | Triglyceride levels in very small VLDL | GCST90093038 | 1.02e-07 |
| 12260 | GALNT5 levels | GCST90469298 | 9.99e-08 |
| 12261 | Triglycerides to total lipids ratio in small VLDL | GCST90092979 | 9.72e-08 |
| 12262 | BSG/LY9 ratio | GCST90313534 | 8.72e-08 |
| 12263 | MAMDC4 levels | GCST90469842 | 8.66e-08 |
| 12264 | Cholesterol to total lipids ratio in small VLDL | GCST90092969 | 8.38e-08 |
| 12265 | SERPINA7 levels | GCST90470587 | 8.13e-08 |
| 12266 | Other and unspecified rosacea | FING00000951 | 7.43e-08 |
| 12267 | Urine 3-hydroxyindolin-2-one sulfate levels in chronic kidney disease | GCST90264508 | 7.39e-08 |
| 12268 | CFHR4 levels | GCST90468727 | 6.72e-08 |
| 12269 | Free cholesterol to total lipids ratio in medium VLDL | GCST90092921 | 6.54e-08 |
| 12270 | ADAM15 levels | GCST90468217 | 6.09e-08 |
| 12271 | Free cholesterol levels in very large HDL | GCST90132680 | 6.01e-08 |
| 12272 | Alzheimer's disease | GCST90027158 | 5.62e-08 |
| 12273 | KEL levels | GCST90469673 | 4.92e-08 |
| 12274 | CD163/ICAM1 ratio | GCST90313735 | 4.91e-08 |
| 12275 | CXCL11/SDC4 ratio | GCST90314336 | 4.18e-08 |
| 12276 | Breakthrough COVID-19 susceptibility after at least one dose of a COVID-19 vaccine | GCST90448695 | 4.06e-08 |
| 12277 | CD48 levels | GCST90468635 | 3.61e-08 |
| 12278 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502068 | 3.13e-08 |
| 12279 | CLEC1A levels | GCST90468767 | 2.94e-08 |
| 12280 | Clonal hematopoiesis (overall) | GCST90435353 | 2.76e-08 |
| 12281 | DSG3/NECTIN4 ratio | GCST90314560 | 2.49e-08 |
| 12282 | Red blood cell (erythrocyte) distribution width | Blood count | UKBB00000748 | 2.43e-08 |
| 12283 | PRSS27 levels | GCST90470342 | 2.42e-08 |
| 12284 | ICAM3 levels | GCST90469500 | 2.25e-08 |
| 12285 | IL27 levels | GCST90469060 | 2.24e-08 |
| 12286 | CEP43/TIA1 ratio | GCST90314021 | 1.88e-08 |
| 12287 | Red blood cell erythrocyte distribution width (UKB data field 30070) | GCST90468099 | 1.78e-08 |
| 12288 | Malignant melanoma, excluding all cancers (controls excluding all cancers) | FING00000750 | 1.75e-08 |
| 12289 | Etiocholanolone glucuronide levels | GCST90199964 | 1.64e-08 |
| 12290 | MCTS1 levels | GCST90469874 | 1.64e-08 |
| 12291 | CLEC4G/KEL ratio | GCST90314119 | 1.62e-08 |
| 12292 | C-reactive protein levels (UKB data field 30710) | GCST90468064 | 1.58e-08 |
| 12293 | SEMA4C levels | GCST90470572 | 1.53e-08 |
| 12294 | CLEC4G levels | GCST90468774 | 1.48e-08 |
| 12295 | Cake icing liking | GCST90094723 | 1.46e-08 |
| 12296 | C1S levels | GCST90468494 | 1.34e-08 |
| 12297 | IL18 levels | GCST90469567 | 1.20e-08 |
| 12298 | EPHB6 levels | GCST90469133 | 1.06e-08 |
| 12299 | Omega-3 fatty acids to total fatty acids percentage | GCST90502448 | 1.05e-08 |
| 12300 | FCGR2A levels | GCST90469200 | 8.53e-09 |
| 12301 | T1 CAT GM unnormalised volume | GCST90383982 | 8.16e-09 |
| 12302 | DSC2 levels | GCST90469040 | 7.43e-09 |
| 12303 | C-reactive protein | Blood biochemistry | UKBB00000113 | 6.48e-09 |
| 12304 | IL1RN levels | GCST90469576 | 5.32e-09 |
| 12305 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502396 | 4.65e-09 |
| 12306 | Other follicular disorders | FING00001050 | 2.52e-09 |
| 12307 | Malignant melanoma of skin, excluding all cancers (controls excluding all cancers) | FING00000749 | 1.48e-09 |
| 12308 | CD74/IL18BP ratio | GCST90313892 | 1.41e-09 |
| 12309 | APBB1IP/POLR2F ratio | GCST90313300 | 1.39e-09 |
| 12310 | SCARB2 levels | GCST90470535 | 1.35e-09 |
| 12311 | VMO1 levels | GCST90471042 | 1.20e-09 |
| 12312 | LY9 levels | GCST90469824 | 1.44e-11 |
| 12313 | GHRL levels | GCST90469341 | 8.51e-12 |